Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scheid

Showing results (1141-1150 of 1,291) with videos related to

Pageof 130
Sort By:
Hematology (Amsterdam, Netherlands)|February 26, 2024
Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trialHans Salwender, Niels Weinhold, Axel Benner, et al.
Vaccine|February 19, 2026
Protective effect of a second booster dose against long COVID among individuals infected with SARS-CoV-2 in southeastern BrazilAna Paula Bandeira Barboza, Alessandra Luna-Muschi, Debora Faffe, et al.
International Journal of Molecular Sciences|June 27, 2024
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income CountriesAnja Seckinger, Hans Salwender, Hans Martin, et al.
Haematologica|April 5, 2015
Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trialMaximilian Merz, Hans Salwender, Mathias Haenel, et al.
Journal of Cancer Research and Clinical Oncology|April 11, 2014
Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemiaMarkus Pfirrmann, Susanne Saussele, Andreas Hochhaus, et al.
European Journal of Haematology|April 4, 2017
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsEMarc-Andrea Baertsch, Jana Schlenzka, Katharina Lisenko, et al.
Blood Advances|July 15, 2024
Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasmsYves Chalandon, Diderik-Jan Eikema, Ivan Moiseev, et al.
Nature|March 17, 2009
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individualsJohannes F Scheid, Hugo Mouquet, Niklas Feldhahn, et al.
Bone Marrow Transplantation|June 6, 2026
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMTGuillaume Dachy, Jarl E Mooyaart, Ludovic Gabellier, et al.
Science (New York, N.Y.)|July 19, 2011
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 bindingJohannes F Scheid, Hugo Mouquet, Beatrix Ueberheide, et al.
Pageof 130

Showing results (1141-1150 of 1,291) with videos related to

Sort By:
Pageof 130
Hematology (Amsterdam, Netherlands)|February 26, 2024
Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trialHans Salwender, Niels Weinhold, Axel Benner, et al.
Vaccine|February 19, 2026
Protective effect of a second booster dose against long COVID among individuals infected with SARS-CoV-2 in southeastern BrazilAna Paula Bandeira Barboza, Alessandra Luna-Muschi, Debora Faffe, et al.
International Journal of Molecular Sciences|June 27, 2024
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income CountriesAnja Seckinger, Hans Salwender, Hans Martin, et al.
Haematologica|April 5, 2015
Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trialMaximilian Merz, Hans Salwender, Mathias Haenel, et al.
Journal of Cancer Research and Clinical Oncology|April 11, 2014
Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemiaMarkus Pfirrmann, Susanne Saussele, Andreas Hochhaus, et al.
European Journal of Haematology|April 4, 2017
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsEMarc-Andrea Baertsch, Jana Schlenzka, Katharina Lisenko, et al.
Blood Advances|July 15, 2024
Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasmsYves Chalandon, Diderik-Jan Eikema, Ivan Moiseev, et al.
Nature|March 17, 2009
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individualsJohannes F Scheid, Hugo Mouquet, Niklas Feldhahn, et al.
Bone Marrow Transplantation|June 6, 2026
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMTGuillaume Dachy, Jarl E Mooyaart, Ludovic Gabellier, et al.
Science (New York, N.Y.)|July 19, 2011
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 bindingJohannes F Scheid, Hugo Mouquet, Beatrix Ueberheide, et al.
Pageof 130